What is the target thyroid‑stimulating hormone (TSH) level during pregnancy for a patient on levothyroxine (Synthroid)?

Target TSH in Pregnancy While on Synthroid

For pregnant women on levothyroxine (Synthroid), the target TSH is <2.5 mIU/L in the first trimester and <3.0 mIU/L in the second and third trimesters. This tight control is essential to prevent adverse pregnancy outcomes including miscarriage, preeclampsia, low birth weight, and neurodevelopmental impairment in the offspring 1, 2, 3.

Target TSH Ranges by Trimester

• First trimester: TSH should be maintained <2.5 mIU/L 1, 2, 3, 4
• Second and third trimesters: TSH should be maintained <3.0 mIU/L 3
• These targets apply to both women with pre-existing hypothyroidism on levothyroxine and those newly diagnosed during pregnancy 2, 3

Levothyroxine Dose Adjustments in Pregnancy

Women with pre-existing hypothyroidism should increase their levothyroxine dose by 25-50% immediately upon pregnancy confirmation 1, 5. This proactive approach is critical because:

• Levothyroxine requirements typically increase by 25-50% during pregnancy in women with pre-existing hypothyroidism 1, 5
• Serum TSH elevations can occur as early as 4 weeks gestation 1
• Delays in achieving target TSH levels are associated with increased miscarriage risk 4

Initial Dosing for Newly Diagnosed Hypothyroidism in Pregnancy

For women newly diagnosed with hypothyroidism during pregnancy, the initial levothyroxine dose should be based on the severity of TSH elevation 3:

• TSH ≤4.2 mIU/L: Start levothyroxine at 1.20 μg/kg/day 3
• TSH 4.2-10 mIU/L: Start levothyroxine at 1.42 μg/kg/day 3
• Overt hypothyroidism (low free T4): Start levothyroxine at 2.33 μg/kg/day 3

These weight-based doses allow most patients (89% with subclinical hypothyroidism, 77% with overt hypothyroidism) to achieve target TSH levels without requiring additional dose adjustments 3.

Monitoring Protocol During Pregnancy

TSH should be measured during each trimester after the dosage is stabilized 1. More specifically:

• Check TSH and free T4 every 4 weeks until stable, then at minimum once per trimester 6
• After any dose adjustment, recheck TSH in 6-8 weeks 1
• The goal is to maintain TSH within trimester-specific reference ranges, ideally <2.5 mIU/L in the first trimester 6, 2

Risks of Inadequate TSH Control

Women with TSH >4.5 mIU/L in the first trimester have a significantly increased risk of miscarriage 4. The risk escalates with higher TSH levels:

• TSH 4.51-10 mIU/L: 1.80-fold increased risk of miscarriage (OR 1.80,95% CI 1.03-3.14) 4
• TSH >10 mIU/L: 3.95-fold increased risk of miscarriage (OR 3.95% CI 1.87-8.37) 4

Additional risks of inadequately treated hypothyroidism during pregnancy include 1, 2:

• Spontaneous abortion
• Preeclampsia
• Stillbirth
• Premature delivery
• Low birth weight
• Adverse effects on fetal neurocognitive development

Real-World Treatment Gaps

In clinical practice, a substantial proportion of pregnant women on levothyroxine fail to achieve guideline-recommended TSH targets 7, 4:

• Only 52.6% of levothyroxine-treated pregnant women had a last recorded TSH value consistent with ATA guidelines 7
• 23.9% were undertreated, and 22.5% did not have TSH monitored during pregnancy 7
• Among levothyroxine-treated women, 62.8% had first-trimester TSH >2.5 mIU/L, with 7.4% having TSH >10 mIU/L 4

Postpartum Management

After delivery, the levothyroxine dosage should return to the pre-pregnancy dose immediately 1. A serum TSH level should be obtained 6-8 weeks postpartum to confirm appropriate dosing 1.

For women who started levothyroxine during pregnancy, the decision to continue long-term therapy depends on 8:

• TSH level at treatment initiation: TSH ≥3.8 mIU/L at diagnosis predicts long-term hypothyroidism (68.5% specificity, 77% sensitivity) 8
• Maximum levothyroxine dose during pregnancy: Doses ≥68.75 μg/day predict long-term hypothyroidism (87% specificity, 42% sensitivity) 8
• Approximately one-third of women who start levothyroxine during pregnancy will require long-term treatment 8

Critical Safety Considerations

Before initiating or increasing levothyroxine in pregnancy, always exclude adrenal insufficiency, especially if central hypothyroidism is suspected 6. Starting thyroid hormone before adequate glucocorticoid coverage can precipitate a life-threatening adrenal crisis 6.

Common Pitfalls to Avoid

• Failing to increase levothyroxine dose immediately upon pregnancy confirmation in women with pre-existing hypothyroidism—this delay increases miscarriage risk 1, 4
• Not monitoring TSH frequently enough during pregnancy—TSH should be checked each trimester at minimum 1
• Using TSH to guide therapy in central hypothyroidism—in this rare condition, free T4 should be maintained in the high-normal range, not TSH 6
• Discontinuing levothyroxine during pregnancy—untreated maternal hypothyroidism has severe consequences for both mother and fetus 1, 2